Mangoceuticals, Inc. focuses to develop, market, and sell various men's wellness products and services through a telemedicine platform. The company is headquartered in Dallas, Texas.
| Revenue (TTM) | 456,020 |
| Gross Profit (TTM) | 250,390 |
| EBITDA | $-15.87M |
| Operating Margin | -1576.00% |
| Return on Equity | -141.70% |
| Return on Assets | -69.90% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $1.13 |
| Price-to-Book | 0.37 |
| Price-to-Sales (TTM) | 13.73 |
| EV/Revenue | 9.65 |
| EV/EBITDA | -0.51 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -10.30% |
| Shares Outstanding | $16.97M |
| Float | $11.15M |
| % Insiders | 10.02% |
| % Institutions | 14.95% |